From: Serum C-reactive protein and procalcitonin values in acute Q fever, scrub typhus, and murine typhus
 | Acute Q fever (n = 115) | Scrub typhus (n = 55) | Murine typhus (n = 19) | Total (n = 189) |
---|---|---|---|---|
Demographics | ||||
 Male | 108 (93.9%) | 33 (60.0%) | 15 (78.9%) | 156 (82.5%) |
 Age (years) (mean ± SD) | 44.8 ± 12.1 | 44.3 ± 16.9 | 49.8 ± 14.6 | 45.1 ± 13.9 |
 Admission | 93 (80.9%) | 52 (94.5%) | 18 (94.7%) | 163 (86.2%) |
 Treatment to defervescence ≤3 days a | 71/89 (79.8%) | 38/50 (76%) | 10/15 (66.7%) | 119/154 (77.3%) |
Underlying conditions | ||||
 Old age (≥65 years) | 10 (8.7%) | 12 (21.8%) | 2 (10.5%) | 24 (12.7%) |
 Hypertension | 13 (11.3%) | 7 (12.7%) | 1 (5.3%) | 21 (11.1%) |
 Diabetes mellitus | 8 (7.0%) | 4 (7.3%) | 2 (10.5%) | 14 (7.4%) |
 COPD | 2 (1.7%) | 0 (0%) | 0 (0%) | 2 (1.1%) |
 Cirrhosis | 1 (0.9%) | 4 (7.3%) | 0 (0%) | 5 (2.6%) |
 Alcoholism | 10 (8.7%) | 3 (5.5%) | 1 (5.3%) | 14 (7.4%) |
 Chronic hepatitis B | 25/108 (23.1%) | 6/46 (13.0%) | 2 /18 (11.1%) | 33/172 (19.2%) |
 Chronic hepatitis C | 9/108 (8.3%) | 3/46 (6.5%) | 1/18 (5.6%) | 13/172 (7.6%) |
 Chronic kidney disease | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
 Heart failure | 2 (1.7%) | 1 (1.8%) | 0 (0%) | 3 (1.6%) |
 Old stroke | 1 (0.9%) | 0 (0%) | 0 (0%) | 1 (0.5%) |
 Hematologic malignancy | 1 (0.9%) | 0 (0%) | 0 (0%) | 1 (0.5%) |
 Solid tumor | 1 (0.9%) | 0 (0%) | 0 (0%) | 1 (0.5%) |
 Connective tissue disease | 0 (0%) | 1 (1.8%) | 0 (0%) | 1 (0.5%) |
Laboratory data (mean ± SD) | ||||
 WBC (/uL) | 6153 ± 2564 | 7650 ± 2657 | 8758 ± 6837 | 6850 ± 3368 |
  Leukocytosis (WBC > 10,000/uL) | 5/115 (4.3%) | 10/55 (18.2%) | 6/19 (31.6%) | 21/189 (11.1%) |
 Hemoglobin (g/dL) | 14.6 ± 1.3 | 12.9 ± 1.7 | 14.0 ± 2.1 | 14.0 ± 1.7 |
  Anemia (Hb < 10 g/dL) | 0/115 (0%) | 3/55 (5.5%) | 0/19 (0%) | 3/189 (1.6%) |
 Platelet (1000/uL) | 139 ± 57 | 137 ± 69 | 148 ± 79 | 139 ± 63 |
  Thrombocytopenia (< 150,000/uL) | 85/115 (73.9%) | 39/55 (70.9%) | 11/19 (57.9%) | 135/189 (71.4%) |
 AST (U/L) | 118 ± 81 | 165 ± 282 | 162 ± 123 | 136 ± 169 |
  AST > 38 U/L | 109/111 (98.2%) | 47/53 (88.7%) | 19/19 (100%) | 175/183 (95.6%) |
 ALT (U/L) | 129 ± 79 | 149 ± 198 | 249 ± 440 | 147 ± 184 |
  ALT> 44 U/L | 111/114 (97.4%) | 42/53 (79.2%) | 18/18 (100%) | 171/185 (92.4%) |